News
Bearish flow noted in Soleno Therapeutics (SLNO) with 4,468 puts trading, or 3x expected. Most active are Apr-25 55 puts and Apr-25 70 calls, ...
Soleno Therapeutics (SLNO) stock jumped over 32% in yesterday’s after-hours trading. The surge came after the company ...
13d
Zacks Investment Research on MSNSLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome DrugShares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR ...
11d
TipRanks on MSNSoleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS TreatmentSoleno Therapeutics ($SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone ...
Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) saw unusually-high trading volume on Monday after HC ...
Soleno Therapeutics, Inc.’s SLNO share price has surged by 35.80%, which has investors questioning if this is right time to ...
Below is Validea's guru fundamental report for SOLENO THERAPEUTICS INC (SLNO). Of the 22 guru strategies we follow, SLNO rates highest using our P/B Growth Investor model based on the published ...
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) traded down 6.7% during mid-day trading on Tuesday ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
$SLNO insiders have traded $SLNO stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales. Here’s a ...
Shares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR (diazoxide choline) extended-release tablets for treating hyperphagia in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results